Antidepressants and public health in Iceland: Time series analysis of national data

British Journal of Psychiatry

Volumn 184, Issue FEB., 2004, Pages 157-162

  Helgason, Tómas ^a,b   Tómasson, Helgi ^a   Zoëga, Tómas ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b NONE   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABILITY; DRUG MARKETING; DRUG USE; HOSPITAL ADMISSION; HUMAN; ICELAND; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREVALENCE; PUBLIC HEALTH; SUICIDE;

EID: 0442291918     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.184.2.157     Document Type: Article

References (27)

1. Agency for Health Care Policy and Research (1999) Treatment of depression - newer pharmacotherapies. Summary. In Evidence Report/Technology Assessment. Number 7, March 1999. Rockville, MD: AHCPR. http://www.ahcpr.gov/ clinic/deprsumm.htm
2. American Psychiatric Association (2000) Practice guidelines for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry, 157 (suppl. 4), 1-45.
3. Ballenger, J., Davidson, R., Lecrubier, Y., et al (1999) Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry, 60 (suppl. 7), 54-61.
4. Bebbington, P., Dunn, G., Jenkins, R., et al (1998) The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychological Medicine, 28, 9-19.
5. Cameron, A. & Trivedi, P. (1998) Regression Analysis of Count Data. Cambridge: Cambridge University Press.
6. Gujarati, D. (1995) Basic Econometrics. New York: McGraw Hill.
7. Harvey, A. (1993) Time Series Models (2nd edn). New York: Harvester Wheatsheaf.
8. Helgason, T. (1990) Depressionernes epidemiologi [The epidemiology of depressions]. Nordisk Psykiatrisk Tidsskrift, 44, 3-12.
9. Helgason, T., Tómasson, K. & Zoëga, T. (2003) Algengi og dreifing notkunar geodeyfoar-kvíoa-og svefnlyfja [Prevalence and distribution of antidepressant, anxiolytic and hypnotic use in 2001]. Lœknablaoio, 89, 15-22.
10. Ihaka, R. & Gentleman, R. (1996) R: a language for data analysis and graphics. Journal of Computational and Graphical Statistics, 5, 299-314.
11. IMS Health (2002) IMS Drug Monitor. Antidepressants Vol. 2002. The Global Health Care Information Company. http://www.imshealth.com/ims/portal/ front/articleC/0,2777,6025_3665_1003594,00.html
12. Isacsson, G. (2000) Suicide prevention - a medical breakthrough? Acta Psychiatrica Scandinavica, 102, 113-117.
13. Khan, A., Warner, H. & Brown, W. (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Archives of General Psychiatry, 57, 311-317.
14. Kisely, S. R. & Goldberg, D. P. (1996) Physical and psychiatric comorbidity in general practice. British Journal of Psychiatry, 169, 236-242.
15. Maris, R. (2002) Suicide. Lancet, 360, 319-326.
16. McClure, G. M. G. (2000) Changes in suicide in England and Wales, 1960-1997. British Journal of Psychiatry, 176, 64-67.
17. Moncrieff, J. (2002) The antidepressant debate. British Journal of Psychiatry, 180, 193-194.
18. Murray, C. & Lopez, A. (1996) The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA: The Harvard School of Public Health on behalf of the World Health Organization and the World Bank.
19. Ornstein, S., Stuart, G. & Jenkins, R. (2000) Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet). Journal of Family Practice, 49, 68-72.
20. Paykel, E. S., Hart, D. & Priest, R. G. (1998) Changes in public attitudes to depression during the Defeat Depression Campaign. British Journal of Psychiatry, 173, 519-522.
21. Retterstöl, N., Ekeberg, Ö. & Mehlum, L. (2002) Selvmond - et personlig og somfunnsmessig problem [Suicide - A Personal and Social Problem]. Oslo: Gyldendal.
22. Simon, G., Katon, W., Von Korff, M., et al (1998) Impact of improved depression treatment in primary care on daily functioning and disability. Psychological Medicine, 28, 693-701.
23. Skýrsla (1996) Könnun á tioni og orsökum sjálfsvíga á Íslandi og tillögur til úrbóta [Survey of Frequency and Causes of Suicide in Iceland]. Reykjavik: Menntamálaráouneytio (Department of Education).
24. Skýrsla (1999) Notkun geodeyfoarlyfja og punglyndisraskanir [Use of antidepressants and depressive disorders]. Lœknablaoio 85 (suppl. 38), 3-26.
25. Statistics Iceland (2002) Statistics Iceland. http://www.hagstofa.is/ template44.asp and http://www.hagstofa.is/template41.asp/
26. Taylor, S., Kingdom, D. & Jenkins, R. (1997) How are nations trying to prevent suicide? An analysis of national suicide prevention strategies. Acta Psychiatrica Scandinavica, 95, 457-463.
27. Williams, J. J., Mulrow, C., Chiquette, E., et al (2000) A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Annals of Internal Medicine, 132, 743-756.